Business Insider

Procyon Technologies LLC and Novo Nordisk A/S to Collaborate on the Development of a Stem-Cell Based Therapy for Type 1 Diabetes

TUCSON, Ariz., Dec. 8, 2020 /PRNewswire/ -- Procyon Technologies LLC today announced that it has entered into an exclusive research collaboration and license agreement with Novo Nordisk A/S to develop ...
UC San Francisco

Innovative Type 1 Diabetes Approach Licensed to Encellin

The cell encapsulation device (right) that is being developed by Encellin, a San Francisco–based biotechnology company. Photo courtesy of Encellin Encellin, a San Francisco-based biotechnology company ...
News Medical

SCT scientists develop Neo-Islet technology for treating insulin-dependent diabetes

The cover of the July 2017 issue of the journal STEM CELLS Translation Medicine showcases the latest advance toward a functional cure of insulin-dependent diabetes. Scientists at SymbioCellTech (SCT), ...
Business Insider

TreeFrog Therapeutics and Invetech Expand Partnership to Transition High-throughput Stem Cell Encapsulation Technology to GMP System for Commercial-scale Cell Therapy Manufacturing

BORDEAUX, France and SAN DIEGO, Oct. 7, 2020 /PRNewswire/ -- TreeFrog Therapeutics, a French biotech leveraging a unique cell manufacturing technology to advance a pipeline of cell therapies with mass ...
Business Wire

Encellin Closes $5.9M Seed Financing Co-Led by Khosla Ventures and SV Latam Capital

Top-tier investor syndicate co-led by Khosla Ventures and SV Latam Capital (SVLC) with participation from Sandhill Angels and Y Combinator The financing will be used to expand the team and prepare its ...